ReviewJournal of experimental & clinical cancer research : CR2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers.
Fengzhi Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.